Village Children
Conditions
Brief summary
Randomisation of 72 large rural areas (blocks) into a 2 x 2 trial of six- monthly treatment of all village children aged 1-5 with albendazole(400mg), vitamin A (200000 iu), both or neither. The placebo group get no trial treatment at all and do not receive physical placebos.
Interventions
DRUGVitamin A
DRUGAlbendazole
Sponsors
United States Agency for International Development (USAID)
University of Oxford
Study design
Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
PREVENTION
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
1 Years to 6 Years
Healthy volunteers
Yes
Inclusion criteria
InclusionCriteria: * Area of residence
Exclusion criteria
* NONE
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| childhood mortality rate at age 1-6 | — |
Secondary
| Measure | Time frame |
|---|---|
| fecal egg counts, plasma retinal, growth, sign of Vitamin A deficiency | — |
Countries
India
Outcome results
None listed